Skip to main content
SpringerLink
Log in

A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease

  • Pharmacodynamics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

There is controversy as to whether effects on mood play a role in mediating the response to corticosteroids in chronic obstructive pulmonary disease (COPD). If alterations in mood are important, it is conceivable that psychotropic drugs such as mianserin might produce similar responses to prednisolone in patients with COPD.

Twelve patients age 62.5 y, with FEV1 29% of predicted and <15% reversibility to salbutamol completed a randomised, double-blind crossover study. After an initial three week placebo run-in period patients received three weeks of prednisolone 40mg daily or mianserin 60–90 mg daily with an intervening three week placebo washout period. Full respiratory function tests, bicycle ergometry and 6 minute walks were performed before and after the run-in and at the end of each period. Psychological and functional assessments were also made at each visit.

Prednisolone significantly increased FVC, maximum ventilation (VEmax) and maximum heart rate (HRmax) compared with placebo, with mean for the difference of 0.251, 2.561 · min−1 and 12 beats · min−1 respectively. FVC, maximum oxygen uptake (VO2max) and HRmax were also significantly increased with prednisolone compared with mianserin. Anxiety scores were significantly lower with prednisolone compared with placebo. In contrast, mianserin had no significant effects on lung function, exercise or psychological parameters compared with placebo.

The improvements in ventilation, exercise and anxiety scores following treatment with prednisolone were not reproduced by mianserin, suggesting that the effects of prednisolone in COPD are unlikely to be due to alterations in mood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wedzicha JA (1993) Inhaled corticosteroids in COPD: awaiting controlled trials. Thorax 48: 305–307

    Google Scholar 

  2. Rudd R (1984) Corticosteroids in chronic bronchitis. BMJ 288: 1553–1554

    Google Scholar 

  3. Weir DC, Burge PS (1993) Effects of high dose inhaled beclomethasone dipropionate 750 μg and 500 μg twice daily and 40 mg per day oral prednisolone on lung function, symptoms and bronchial hyperresponsiveness in patients with non asthmatic chronic airflow obstruction. Thorax 48: 309–316

    Google Scholar 

  4. Harding SM, Freedman S (1978) A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response. Thorax 33: 214–218

    Google Scholar 

  5. Weir DC, Gove RI, Robertson AS, Burge PS (1990) Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 45: 112–117

    Google Scholar 

  6. Auffaith B, Postma DS, de Manchy JGR, Kander Mark Th W, Boorsma M, Koeter GH (1991) Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness and cough threshold in smokers with chronic obstructive lung disease. Thorax 46: 372–377

    Google Scholar 

  7. Mitchell DM, Gildeh P, Rehahn M, Dimond AM, Collins JV (1984) Effects of prednisolone in chronic airflow limitation. Lancet II: 193–195

    Google Scholar 

  8. Mendella LA, Manfreda J, Warren CPW, Anthonisen NR (1982) Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med (1982) 96: 17–21

    Google Scholar 

  9. Mitchell DM, Gildeh P, Rehahn M, Diamond AM, Collins JV (1984) Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment. Thorax 39: 924–927

    Google Scholar 

  10. Ling MHM, Perry PJ, Ming TT (1981) Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry 38: 471–477

    Google Scholar 

  11. Morgan AD, Peck DF, Buchanon DR, McHardy GJR (1983) Effects of attitudes and beliefs on exercise tolerance in chronic bronchitis. BMJ 286: 171–173

    Google Scholar 

  12. Rutter BM (1977) Some psychological concomitants of chronic bronchitis. Psychol Medicine 7: 459–464

    Google Scholar 

  13. Oswald NC, Waller RE, Drinkwater J (1970) Relationship between breathlessness and anxiety in asthma and bronchitis. A comparative study. BMJ 2: 14–17

    Google Scholar 

  14. Marshall RJ (1983) The pharmacology of mianserin — an update. Br J Clin Pharmacol 15: 263S-268S

    Google Scholar 

  15. American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Resp Dis 137: 225–244

    Google Scholar 

  16. American Thoracic Society (1987) Standardisation of spirometry — 1987 Update. Am Rev Resp Dis 136: 1285–1298

    Google Scholar 

  17. Borg G (1970) Perceived exertion as an indicator of somatic stress. Scand J Rehab Med 2–3: 92–98

    Google Scholar 

  18. Eysenck HJ, Eysenck SBG (1964) Manual of the Eysenck personality inventory. Hodder & Stoughton, Kent

    Google Scholar 

  19. Crown S, Crisp AH (1966) A short clinical diagnostic self-rating scale for psychoneurotic patients. Br J Psychiatry 112: 917–923

    Google Scholar 

  20. Cooper P, Osborn M, Gath D, Feggetter G (1982) Evaluation of a modified self-report measure of social adjustment. Br J Psychiatry 141: 68–75

    Google Scholar 

  21. Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA, McDevitt DG (1989) Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 37: 567–571

    Google Scholar 

  22. Brown RA, Swanson Beck J (1990) Comparison of several groups: the analysis of variance. In: Brown RA, Swanson Beck J (eds) Medical statistics on Microcomputers. BMJ Publications, London pp 34–42

    Google Scholar 

  23. Mungall IPF, Hainsworth R (1979) Assessment of respiratory function in patients with chronic obstructive airways disease. Thorax 34: 254–258

    Google Scholar 

  24. Newnham DM, Dhillon DP, Winter JM, Jackson CM, Clark RA, Lipworth BJ (1993) Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease. Thorax 48: 1151–1155

    Google Scholar 

  25. Bellamy D, Hutchison DCS (1981) The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema. Br J Dis Chest 75: 190–196

    Google Scholar 

  26. Connellan SJ, Gough SE (1982) The effects of nebulised salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction. Br J Dis Chest 76: 135–142

    Google Scholar 

  27. Tweedale PH, Alexander F, McHardy GJR (1987) Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 42: 487–490

    Google Scholar 

  28. Chrystyn H, Mulley BA, Peake MD (1988) Dose response relation to oral theophylline in severe chronic obstructive airways disease Br Med J 297: 1506–1510

    Google Scholar 

  29. Spiro SG, Hahn HL, Edwards RHT, Pride NB (1974) Cardiorespiratory adaptations at the start of exercise in normal subjects and in patients with chronic obstructive bronchitis. Clin Sci Mol Med 47: 165–172

    Google Scholar 

  30. Belman MJ (1993) Exercise in patients with chronic obstructive pulmonary disease. In: Muir JF, Pierson DJ (eds) Pulmonary rehabilitation in chronic respiratory insufficiency. Thorax 48: 936–946

    Google Scholar 

  31. Coppen A, Gupta R, Montgomery S, Ghose K, Bailey J, Burns B, de Ridder JJ (1976) Mianserin Hydrochloride: a novel antidepressant. Br J Psychiatry 129: 342–345

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Ninewells Hospital and Medical School, DD1 9SY, Dundee, Scotland, UK

    A. Grove & B. J. Lipworth

  2. Department of Respiratory Medicine, King's Cross Hospital, DD38EA, Dundee, Scotland, UK

    C. G. Ingram, R. A. Clark & D. P. Dhillon

Authors
  1. A. Grove
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. J. Lipworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. G. Ingram
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. A. Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. P. Dhillon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grove, A., Lipworth, B.J., Ingram, C.G. et al. A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease. Eur J Clin Pharmacol 48, 13–18 (1995). https://doi.org/10.1007/BF00202165

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00202165

Key words

Search

Navigation